Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection Idan Goren Henit Yanai iris dotan academic.oup.com/ecco-jcc/advan…

Does antibiotic prophylaxis favor multi-resistant bacteria in cirrhosis ? If so, should we stop giving prophylaxis after a SBP episode ? This paper in nature shows that widespread prophylaxis with Rifaximin can lead to total resistance to antibiotics ! t.ly/cRy9X

Study demonstrates the contribution of gut pathobionts in releasing OMVs that traverse the mucosal barrier and, thus, promote #liver inflammation and fibrosis in PSC-IBD. 🔗 ow.ly/AnZi50TZi3h 🖋️ @MIB_GuentherLab

Happy birthday to Marie Skłodowska Curie, who was born on this day in 1867. Marie Curie was the first person to be awarded the Nobel Prize twice, and is still the only individual to receive the prize in two different science categories. Find out more: bit.ly/2EQeIam

Honored to be part of it 🎉 Many thanks for a very fruitful meeting. So many aspects covered. Great work by all coordinators, WG leaders, patients, all experts and #ECCO officers involved.

#GUTAbstract on the paper by Pierre et al entitled "External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn’s disease stopping infliximab" via bit.ly/40Buqyw Paper: bit.ly/3X7tRug GIGA-ULiège

What’s the evidence regarding Advanced Combination Treatment (ACT) in #IMIDs? SR&MA including 10 RCTs ❗️ACT no clinical benefit in rheumatological IMIDs & resulted in ⬆️rate AEs in rheumatoid arthritis ❇️ACT may offer clinical benefit without a clear safety signal in #IBD

Drodzy! Zapraszamy na I edycję konferencji gastrochirurgicznej, którą organizuję z prof. Tomkiem Banasiewiczem w dniach 22-23.11.2024r. Stawiamy na: 👉praktykę 👉interakcję 👉interdyscyplinarność Do zobaczenia w Poznaniu! ddby5fyjfr4yv.cloudfront.net/inne/media/202…

Happy to share our latest 🇵🇱real-world data on the impact of VDZ on 👉fatigue 👉QoL 👉different PROs in Crohn's disease. The POLONEZ II Study #IBD #GITwitter Therapeutic Advances in Gastroenterology Y-ECCO Seb Jan Král journals.sagepub.com/doi/10.1177/17…

Co trzeba uznać za priorytet w kontekście odpowiedzialności konsultanta wojewódzkiego w gastroenterologii, jaka jest infrastruktura oddziałów w Poznaniu i jakie są największe wyzwania w tej dziedzinie medycyny? Na te pytania odpowiada prof. Piotr Eder. termedia.pl/kurier-medyczn…

#GUTImage from the paper by Jacobs et al entitled "Age-related patterns of microbial dysbiosis in multiplex inflammatory bowel disease families" via bit.ly/4flRHcp #IBD

📄 Long-term vedolizumab therapy for Crohn’s disease shows significant improvements: 63.3% response rate, 48% remission, and better PROs (CDAI, IBDQ, IBD-F). POLONEZ II confirms VDZ's real-world benefits over 54 weeks 🔗 journals.sagepub.com/doi/epdf/10.11…

Fantastic 1st day of #AIBD2024 🎉 💥New concepts 💥Evolving, aspirational goals 💥MDT-based approach 💥Future directions 💣...but still huge basic educational gaps and needs in 2024 Happy to be here together with other 🇵🇱 IBDologists

#AIBD24 Advances in IBD #Proctitis Michael Chiorean 💎20% need Rx 📈 💎Under-represented in RCT 💎What’s after PO/topical 5ASA or topical steroids ✅Topical Tacro ✅TNFi, JAKi ✅#Etrasimod only RCT (treat through) data in UP 📸Algo on treating isolated or residual proctitis👇🏽

#aibd 💥Upper GI Crohn's disease: 👉Underestimated epidemiology? 👉Indicates more severe course 👉Needs aggressive Tx + acid suppression

🔬🚀 #CrohnsDisease News‼️ 🔗📘 tinyurl.com/ydwentvd ✅The REPREVIO trial tested early vedolizumab use after ileocolonic surgery to prevent recurrence. 💡Let’s see what happened⬇️ #IBD #GiTwitter #MedTwitter #MedEd #Crohns my_UEG Y-ECCO The Lancet Gastroenterology & Hepatology

#CGH4ALL CGH 📣 🔥American Gastroenterological Association (AGA) Clinical Practice Update on Endoscopic Scoring Systems in IBD🎯 📚 Adv imaging such as chromoendoscopy can reflect fine patterns seen histologically🔬 👀 Read more at 🔗 doi.org/10.1016/j.cgh.…  Marietta Iacucci Francis (Frank) Farraye, MD, MSc @Dcharabaty

Drinking more than 3 cups of coffee, especially in the mornings rather than throughout the day, may be one of the easiest ways to increase survival! Hurray for coffee…in the mornings 🤪☕️ academic.oup.com/eurheartj/adva…

Na stronie pulsmedycyny.pl już 17 lutego zobaczycie jak głosowali m.in. Aleksander Biesiada Piotr Chłosta Piotr Eder Piotr Jankowski Piotr Rutkowski Agnieszka Szuster-Ciesielska Michał Byliniak 𝗚𝗿𝘇𝗲𝗴𝗼𝗿𝘇 𝗖𝗲𝘀𝘀𝗮𝗸 Arkadiusz Grądkowski Marcin Czech Tomasz Dybek Jaroslaw J. Fedorowski Małgorzata Gałązka -Sobotka